Nano-X Imaging (NASDAQ:NNOX - Get Free Report) was upgraded by research analysts at Cantor Fitzgerald to a "strong-buy" rating in a research note issued on Wednesday,Zacks.com reports.
Several other equities research analysts also recently issued reports on NNOX. Weiss Ratings reiterated a "sell (d-)" rating on shares of Nano-X Imaging in a research note on Monday, December 29th. D. Boral Capital restated a "buy" rating and set a $5.00 target price on shares of Nano-X Imaging in a report on Tuesday. Finally, LADENBURG THALM/SH SH upgraded Nano-X Imaging to a "strong-buy" rating in a report on Thursday, November 20th. Three analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, Nano-X Imaging has an average rating of "Buy" and an average target price of $7.00.
Read Our Latest Research Report on NNOX
Nano-X Imaging Price Performance
NASDAQ NNOX opened at $2.65 on Wednesday. Nano-X Imaging has a 1-year low of $2.11 and a 1-year high of $6.42. The firm has a market capitalization of $173.26 million, a P/E ratio of -2.01 and a beta of 1.38. The business's 50-day simple moving average is $2.72 and its 200-day simple moving average is $3.39.
Institutional Inflows and Outflows
Several hedge funds have recently made changes to their positions in the company. Aristides Capital LLC bought a new position in shares of Nano-X Imaging during the fourth quarter valued at approximately $30,000. Virtu Financial LLC increased its position in Nano-X Imaging by 26.4% in the fourth quarter. Virtu Financial LLC now owns 72,535 shares of the company's stock worth $203,000 after buying an additional 15,169 shares during the period. Millennium Management LLC acquired a new position in shares of Nano-X Imaging during the fourth quarter valued at $91,000. Engineers Gate Manager LP grew its position in shares of Nano-X Imaging by 272.2% during the fourth quarter. Engineers Gate Manager LP now owns 52,844 shares of the company's stock worth $148,000 after acquiring an additional 38,648 shares during the last quarter. Finally, Weiss Asset Management LP bought a new stake in Nano-X Imaging in the 4th quarter valued at about $8,424,000. Institutional investors and hedge funds own 21.49% of the company's stock.
About Nano-X Imaging
(
Get Free Report)
Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.
The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nano-X Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nano-X Imaging wasn't on the list.
While Nano-X Imaging currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.